[go: up one dir, main page]

BR9305482A - Processo de evocar em um hospedeiro mamífero uma resposta imune protetora contra infecção por helicobacter, composição de vacina adequada para o tratamento de infecção por helicobacter, vacina, processo de proporcionar proteção passiva a um hospedeiro mamífero contra infecção por helicobacter, anticanticorpo monoclonal e linhagem celular - Google Patents

Processo de evocar em um hospedeiro mamífero uma resposta imune protetora contra infecção por helicobacter, composição de vacina adequada para o tratamento de infecção por helicobacter, vacina, processo de proporcionar proteção passiva a um hospedeiro mamífero contra infecção por helicobacter, anticanticorpo monoclonal e linhagem celular

Info

Publication number
BR9305482A
BR9305482A BR9305482A BR9305482A BR9305482A BR 9305482 A BR9305482 A BR 9305482A BR 9305482 A BR9305482 A BR 9305482A BR 9305482 A BR9305482 A BR 9305482A BR 9305482 A BR9305482 A BR 9305482A
Authority
BR
Brazil
Prior art keywords
helicobacter infection
mammalian host
vaccine
against helicobacter
evoking
Prior art date
Application number
BR9305482A
Other languages
English (en)
Inventor
Steven James Czinn
John Gilbert Nedrud
Original Assignee
Steven James Czinn
John Gilbert Nedrud
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25351374&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9305482(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Steven James Czinn, John Gilbert Nedrud filed Critical Steven James Czinn
Publication of BR9305482A publication Critical patent/BR9305482A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/121—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Helicobacter (Campylobacter) (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55544—Bacterial toxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
BR9305482A 1992-04-13 1993-04-09 Processo de evocar em um hospedeiro mamífero uma resposta imune protetora contra infecção por helicobacter, composição de vacina adequada para o tratamento de infecção por helicobacter, vacina, processo de proporcionar proteção passiva a um hospedeiro mamífero contra infecção por helicobacter, anticanticorpo monoclonal e linhagem celular BR9305482A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86828692A 1992-04-13 1992-04-13
PCT/US1993/003409 WO1993020843A1 (en) 1992-04-13 1993-04-09 Oral treatment of helicobacter infection

Publications (1)

Publication Number Publication Date
BR9305482A true BR9305482A (pt) 1994-10-04

Family

ID=25351374

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9305482A BR9305482A (pt) 1992-04-13 1993-04-09 Processo de evocar em um hospedeiro mamífero uma resposta imune protetora contra infecção por helicobacter, composição de vacina adequada para o tratamento de infecção por helicobacter, vacina, processo de proporcionar proteção passiva a um hospedeiro mamífero contra infecção por helicobacter, anticanticorpo monoclonal e linhagem celular

Country Status (17)

Country Link
US (1) US5538729A (pt)
EP (1) EP0590138A4 (pt)
JP (1) JPH07500845A (pt)
BG (1) BG61935B1 (pt)
BR (1) BR9305482A (pt)
CA (1) CA2111189A1 (pt)
CZ (1) CZ273093A3 (pt)
FI (1) FI935591A7 (pt)
HU (1) HU214699B (pt)
MX (1) MX9301706A (pt)
NO (1) NO934547D0 (pt)
NZ (1) NZ251849A (pt)
OA (1) OA10213A (pt)
RU (1) RU2107513C1 (pt)
SG (1) SG52556A1 (pt)
SK (1) SK281238B6 (pt)
WO (1) WO1993020843A1 (pt)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2682122B1 (fr) * 1991-10-03 1995-06-09 Pasteur Institut Nouveaux genes d'helicobacter pylori. leur utilisation pour la preparation de souches recombinantes de h. pylori.
ATE273021T1 (de) * 1992-02-26 2004-08-15 Univ Vanderbilt Gereinigtes vakuolisierendes toxin aus helicobacter pylori und methoden zu dessen verwendung
US7141244B1 (en) * 1992-03-02 2006-11-28 Chiron Srl Helicobacter pylori proteins useful for vaccines and diagnostics
MX9301706A (es) * 1992-04-13 1994-05-31 Oravax Inc Composicion de vacuna para el tratamiento de la infeccion por helicobacter.
US5972336A (en) * 1992-11-03 1999-10-26 Oravax Merieux Co. Urease-based vaccine against helicobacter infection
US6290962B1 (en) * 1992-11-03 2001-09-18 Oravax, Inc. Urease-based vaccine and treatment for helicobacter infection
JPH08509873A (ja) 1993-05-19 1996-10-22 アンスティテュ・パストゥール ヘリコバクター感染に対する免疫組成物、該組成物に用いられるポリペプチドおよび該ポリペプチドをコードする核酸配列
US5843460A (en) * 1993-05-19 1998-12-01 Institut Pasteur Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions, and nucleic acid sequences encoding said polypeptides
US6406703B1 (en) 1993-07-27 2002-06-18 Csl Limited Treatment of H. pylori associated gastroduodenal disease
CA2154063C (en) * 1993-07-27 2006-11-21 Christopher Vincent Doidge Treatment of h. pylori associated gastroduodenal disease
AUPM399594A0 (en) 1994-02-21 1994-03-17 Csl Limited Antigenic preparation for treatment or prevention of helicobacter infection
AUPM612494A0 (en) * 1994-06-08 1994-06-30 Csl Limited Treatment or prevention of helicobacter infection
AU702878B2 (en) * 1994-06-08 1999-03-11 Csl Limited Treatment and prevention of helicobacter infection
US5780040A (en) * 1994-06-08 1998-07-14 Tufts University School Of Medicine Hospital, Inc. Helicobacter pylori nickel binding protein
JPH10502366A (ja) * 1994-07-01 1998-03-03 リカン・リミテッド ヘリコバクター・ピロリ抗原タンパク質調製品およびイムノアッセイ
DE69534635T2 (de) * 1994-10-05 2006-09-21 Emergent Immunosolutions Inc. Verfahren zur produktion von verstärkt antigen wirkenden heliobacter sp. und vakzine die diesen enthalten
US5897475A (en) * 1994-10-05 1999-04-27 Antex Biologics, Inc. Vaccines comprising enhanced antigenic helicobacter spp.
FR2732605B1 (fr) * 1995-04-07 1997-05-16 Pasteur Merieux Serums Vacc Composition destinee a l'induction d'une reponse immunitaire mucosale
AR003125A1 (es) * 1995-06-01 1998-07-08 Astra Ab Antigenos bacterianos para el diagnostico de infecciones con helicobacter pylori, una molecula de adn que lo codifica, un vector, una celula huesped,procedimiento para producir el polipeptido, composiciones para vacunas adecuadas para uso terapeutico y profilactico, el uso del polipeptido en la
AU3657995A (en) * 1995-10-09 1997-04-30 Pasteur Merieux Serums Et Vaccins Helicobacter lactoferrin receptor
GB2307987A (en) * 1995-12-06 1997-06-11 Univ Manchester Epitopes of the urease of Helicobacter pylori as dignostic agents; pharmaceuticals comprising such epitopes or the antibodies thereto
BR9612090A (pt) 1995-12-19 1999-12-28 Univ Iowa State Res Found Inc Vacina para aves domésticas heterófilo-adaptada
PT909323E (pt) * 1996-01-04 2007-06-04 Novartis Vaccines & Diagnostic ''bacterioferritina de helicobacter pilori''
EP0909272B1 (en) * 1996-06-10 2007-02-07 Borén, Thomas Helicobacter pylori adhesin binding group antigen
US20020026035A1 (en) * 1997-04-01 2002-02-28 Harold Kleanthous Helicobacter ghpo 1360 and ghpo 750 polypeptides and corresponding polynucleotide molecules
JP2001523954A (ja) * 1997-04-01 2001-11-27 メリウクス オラバクス ７６ ｋＤａ、３２ ｋＤａ、および５０ ｋＤａヘリコバクター（Ｈｅｌｉｃｏｂａｃｔｅｒ）ポリペプチドおよび対応するポリヌクレオチド分子
US20030124141A1 (en) * 1997-04-01 2003-07-03 Rainer Haas Helicobacter polypeptides and corresponding polynucleotide molecules
JP3430853B2 (ja) * 1997-04-11 2003-07-28 株式会社ゲン・コーポレーション 胃炎、胃潰瘍および十二指腸潰瘍の予防剤並びに治療剤
SE9702240D0 (sv) * 1997-06-12 1997-06-12 Astra Ab Vaccine compositions III
KR100509817B1 (ko) * 1997-06-27 2005-12-16 씨제이 주식회사 비브리오불니피쿠스의감염예방을위한경구용백신
US20030158396A1 (en) * 1997-07-29 2003-08-21 Harold Kleanthous Identification of polynucleotides encoding novel helicobacter polypeptides in the helicobacter genome
US6599509B2 (en) * 1997-09-02 2003-07-29 Massachusetts Institute Of Technology Compositions and methods comprising helicobacter antigens for treatment and prevention of inflammatory bowel disease
US5985631A (en) 1997-09-12 1999-11-16 Oravax-Merieux Co. Method for preventing the activation of inactive, recombinant Helicobacter pylori apourease
SE9801288D0 (sv) 1998-04-14 1998-04-14 Astra Ab Vaccine delivery system and metod of production
US6585975B1 (en) * 1998-04-30 2003-07-01 Acambis, Inc. Use of Salmonella vectors for vaccination against helicobacter infection
JP2002518343A (ja) 1998-06-19 2002-06-25 メリウクス オラバクス ヘリコバクター感染に対する非経口的免疫処置法におけるｌｔおよびｃｔ
US7087236B1 (en) 1998-09-01 2006-08-08 Merrion Research I Limited Method for inducing a cell-mediated immune response and improved parenteral vaccine formulations thereof
RU2182486C2 (ru) * 2000-04-25 2002-05-20 Юсупов Гамзат Абдуллаевич Способ лечения язвенной болезни двенадцатиперстной кишки и лекарственный препарат для его осуществления
US20020107368A1 (en) * 2000-12-07 2002-08-08 Jing-Hui Tian Helicobacter proteins, gene sequences and uses thereof
US20050175629A1 (en) * 2001-08-31 2005-08-11 Giuseppe Del Giudice Helicobacter pylori vaccination
US7790143B2 (en) * 2005-06-16 2010-09-07 Universiteit Gent Vaccines for immunization against helicobacter
ATE516817T1 (de) * 2005-06-16 2011-08-15 Univ Gent Impfstoffe zur immunisierung gegen helicobacter

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5417986A (en) * 1984-03-16 1995-05-23 The United States Of America As Represented By The Secretary Of The Army Vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres
US5268276A (en) * 1988-09-16 1993-12-07 Jan Holmgren Recombinant systems for expression of cholera B-sub-unit with the aid of foreign promoters and/or leader peptides
FR2637612B1 (fr) * 1988-10-06 1993-09-10 Pasteur Institut Sequences de nucleotides codant pour une proteine a activite ureasique
DE4139840B4 (de) * 1990-12-04 2005-06-02 Quidel Corp., San Diego Antigen-Zubereitung zum Nachweis von H. pylori
EP0582672A4 (en) 1991-04-26 1994-06-29 Emanuel Calenoff Methods to detect and treat diseases caused by bacterial allergens
FR2682122B1 (fr) * 1991-10-03 1995-06-09 Pasteur Institut Nouveaux genes d'helicobacter pylori. leur utilisation pour la preparation de souches recombinantes de h. pylori.
ATE273021T1 (de) * 1992-02-26 2004-08-15 Univ Vanderbilt Gereinigtes vakuolisierendes toxin aus helicobacter pylori und methoden zu dessen verwendung
WO1993018150A1 (en) * 1992-03-02 1993-09-16 Biocine S.P.A. Helicobacter pylori proteins useful for vaccines and diagnostics
MX9301706A (es) * 1992-04-13 1994-05-31 Oravax Inc Composicion de vacuna para el tratamiento de la infeccion por helicobacter.

Also Published As

Publication number Publication date
FI935591A0 (fi) 1993-12-13
HUT67058A (en) 1995-01-30
HU9303561D0 (en) 1994-04-28
AU3977093A (en) 1993-11-18
RU2107513C1 (ru) 1998-03-27
SG52556A1 (en) 1998-09-28
FI935591L (fi) 1994-02-11
US5538729A (en) 1996-07-23
CZ273093A3 (en) 1994-04-13
EP0590138A4 (en) 1996-01-24
AU675938B2 (en) 1997-02-27
CA2111189A1 (en) 1993-10-28
WO1993020843A1 (en) 1993-10-28
MX9301706A (es) 1994-05-31
NO934547D0 (no) 1993-12-10
BG98294A (bg) 1995-02-28
JPH07500845A (ja) 1995-01-26
HU214699B (hu) 1998-04-28
NZ251849A (en) 1997-06-24
FI935591A7 (fi) 1994-02-11
OA10213A (en) 1997-10-07
SK281238B6 (sk) 2001-01-18
BG61935B1 (bg) 1998-10-30
SK141293A3 (en) 1994-07-06
EP0590138A1 (en) 1994-04-06

Similar Documents

Publication Publication Date Title
BR9305482A (pt) Processo de evocar em um hospedeiro mamífero uma resposta imune protetora contra infecção por helicobacter, composição de vacina adequada para o tratamento de infecção por helicobacter, vacina, processo de proporcionar proteção passiva a um hospedeiro mamífero contra infecção por helicobacter, anticanticorpo monoclonal e linhagem celular
BR8300475A (pt) Composto, composicao farmaceutica, processo para tratamento de infeccao virotica em um animal de sangue quente ou de sangue frio, e processo para a preparacao de tal composto
IT1215802B (it) Procedimento per sorvegliare e/oppure controllare il processo di incannatura nonche' punto di incannatura per attuare detto procedimento.
BR9307804A (pt) Laminado de vidro inquebrável curvado e processo para formar o laminado
ES2176232T3 (es) Vacuna adecuada para ser utilizada en la prevencion y tratamiento de la infeccion por helicobacter.
BR8703552A (pt) Processo para preparar peptidio,peptidio antigenico,anticorpos imunoespecificos,peptidio,processo para avaliacao da presenca do hpv em uma amostra,processo para protecao de uma materia em oposicao a infeccao de hpv,processo para avaliacao de estagio da infeccao por hpv em biopsias ou esfregacos cervicais e processo para imunoterapia passiva contra a infeccao por hpv
BR9102672A (pt) Composicao para exterminar microorganismos, composicao para exterminar virus envelopados, processo para exterminar microorganismos em ou sobre um hospedeiro e processo para exterminar virus envelopados em um ser humano ou animal de sangue quente, hospedeiro
DK154789D0 (da) Avendelse af topisk paafoerbare praeparater til behandling af aeldet hud
LV10203A (lv) Panemiens inficesanas ar AIDS noteiksanai olbaltumvielu kompozicija test-komplekts
DE69304521D1 (de) Impfstoff Adjuvans
IT1233486B (it) Metodo e dispositivo per l'avanzamento, in successione, di prodotti appiattiti
BR8707471A (pt) Vacina e processo de preparacao
IT8167857A0 (it) Procedimento e dispositivo per la deidrogenazione in linea di preforme per fibre ottiche
BR9202024A (pt) Virus de apivox recombinante,cultura de celulas eucariotica infectadas por um virus de avipox,vacina,sequencia de transferencia e plasmideo
IT8721401A0 (it) Impianto di frenatura con protezione antoblocco e regolazione dello scorrimento di azionamento.
IT1220385B (it) Metodo e dispositivo per l'avanzamento,in successione,di prodotti appiattiti
DK0541692T3 (da) Herpes simplex virus VP-16-vacciner
IT1186348B (it) Dispositivo per il caricamento di um impianto per l'elaborazione di prodotti piatti pieghevoli,e in particolare di prodotti da stampare
PT88524A (pt) Process of preparation of a vaccine for the protection of birdsagainst contagions by mycoplasma and the preparation of a pure culture of the same
BR9007070A (pt) Vacina para o tratamento preventivo de infeccao por vermes trematoides do figado em ruminantes
BR9204412A (pt) Metodo para proteger um animal vertebrado contra um parasita,metodo para inibir o crescimento de organismos parasiticos nas fezes de um animal de sangue quente,composicao parasiticida e composto
IT1135680B (it) Procedimento per la manipolazione di prodotti stampati,come pure mezzi e dispositivo per l'esecuzione dello stesso
GB9410856D0 (en) Antigen to confer protective immunity against helminthic infections of humans and animals and process of vaccination for application in the immunoprophylaxix
ITMO920106A1 (it) Impianto per l'esecuzione della tempra, in particolare, di lastre di vetro e simili
AU1948788A (en) Expression of immunologically active proteins of human b-lymphotropic virus

Legal Events

Date Code Title Description
EE Request for examination
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal
HIFC Refusal cancelled
FC Decision: refusal
B15K Others concerning applications: alteration of classification

Ipc: A61K 39/02 (2006.01), C07K 16/12 (2006.0